Subscribe to our Newsletters !!
Like never seen before, coral reefs across the
Labs today face mounting pressure to cut carbon em
Dr. Mohammed Enayat’s recent testimony on his ag
It is with utmost pride that Microbioz India annou
30th June, 2025 Mumbai: Alembic Pharmaceuticals Li
Since it’s an ingredient in so many foods, you h
In our cover story, we shine a spotlight on “ The Magazine
Eli Lilly and Co said on Tuesday the clinical trial of its COVID-19 antibody treatment similar to one taken by US President Donald Trump has been paused due to a safety concern. Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as compared to a treatment in a movie he submitted last week.
The announcement comes one day after Johnson & Johnson said it was forced to pause a large high-profile trial of its experimental coronavirus vaccine as a volunteer fell ill. J&J said it doesn’t know if that individual was given the vaccine or a placebo.
AstraZeneca Plc’s US trial for its experimental COVID-19 vaccine has also been on hold for over a month following a volunteer in its UK study fell ill. Trials of the vaccine resumed in other areas after a short halt.
Lilly said earlier this month it was applying for emergency use authorization (EUA) for its antibody drug, LY-CoV555, for patients with mild to moderate COVID-19 according to data from another clinical trial.
